Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   NO and hepatocellular cancer
  2. Wang, Ronghua; Geller, David A.; Wink,David; Cheng, Bin; Billiar, Timothy R.
  3. British journal of pharmacology. 2019, Dec 11;
  1. 2.   Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation
  2. Schmid, T.; Bajer, M. M.; Blees, J. S.; Eifler, L. K.; Milke, L.; Rubsamen, D.; Schulz, K.; Weigert, A.; Baker, A. R.; Colburn, N. H.; Brune, B.
  3. Carcinogenesis. 2011, Oct; 32(10): 1427-1433.
  1. 3.   Downregulation of Programmed Cell Death 4 by Inflammatory Conditions Contributes to the Generation of the Tumor Promoting Microenvironment
  2. Yasuda, M.; Schmid, T.; Rubsamen, D.; Colburn, N. H.; Irie, K.; Murakami, A.
  3. Molecular Carcinogenesis. 2010, Sep; 49(9): 837-848.
  1. 4.   Nuclear Accumulation of beta-Catenin Protein Indicates Activation of wnt Signaling in Chemically Induced Rat Nephroblastomas
  2. Ehrlich, D.; Bruder, E.; Thome, M. A.; Gutt, C. N.; Doeberitz, M. V.; Niggli, F.; Perantoni, A. O.; Koesters, R.
  3. Pediatric and Developmental Pathology. 2010, Jan-Feb; 13(1): 1-8.
  1. 5.   Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
  2. Salcedo, R.; Hixon, J. A.; Stauffer, J. K.; Jalah, R.; Brooks, A. D.; Khan, T.; Dai, R. M.; Scheetz, L.; Lincoln, E.; Back, T. C.; Powell, D.; Hurwitz, A. A.; Sayers, T. J.; Kastelein, R.; Pavlakis, G. N.; Felber, B. K.; Trinchieri, G.; Wigginton, J.
  3. Journal of Immunology. 2009 182(7): 4328-4338.
  1. 6.   Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer
  2. Schneider, B. J.; Worden, F. P.; Gadgeel, S. M.; Parchment, R. E.; Hodges, C. M.; Zwiebel, J.; Dunn, R. L.; Wozniak, A. J.; Kraut, M. J.; Kalemkerian, G. P.
  3. Investigational New Drugs. 2009 27(6): 571-578.
  1. 7.   Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction
  2. Yasuda, M.; Nishizawa, T.; Ohigashi, H.; Tanaka, T.; Hou, D. X.; Colburn, N. H.; Murakami, A.
  3. Carcinogenesis. 2009 30(7): 1209-1216.
  1. 8.   Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
  2. Barkan, D.; Kleinman, H.; Simmons, J. L.; Asmussen, H.; Kamaraju, A. K.; Hoenorhoff, M. J.; Liu, Z. Y.; Costes, S. V.; Cho, E. H.; Lockett, S.; Khanna, C.; Chambers, A. F.; Green, J. E.
  3. Cancer Research. 2008 68(15): 6241-6250.
  1. 9.   Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): Novel marker for cervical carcinogenesis
  2. Miyatake, T.; Ueda, Y.; Nakashima, R.; Yoshino, K.; Kimura, T.; Murata, T.; Nomura, T.; Fujita, M.; Buzard, G. S.; Enomoto, T.
  3. International Journal of Cancer. 2007, May; 120(10): 2068-2077.
  1. 10.   Targeted therapy for cancer stem cells: the patched pathway and ABC transporters
  2. Lou, H.; Dean, M.
  3. Oncogene. 2007, Feb; 26(9): 1357-1360.
  1. 11.   Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines
  2. Romanowska, M.; Kikawa, K. D.; Fields, J. R.; Maciag, A.; North, S. L.; Shiao, Y. H.; Kasprzak, K. S.; Anderson, L. M.
  3. Lung Cancer. 2007, Jan; 55(1): 35-42.
  1. 12.   Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin
  2. Madiraju, C.; Edler, M. C.; Hamel, E.; Raccor, B. S.; Balachandran, R.; Zhu, G. Y.; Giuliano, K. A.; Vogt, A.; Shin, Y. S.; Fournier, J. H.; Fukui, Y. H.; Bruckner, A. M.; Curran, D. P.; Day, B. W.
  3. Biochemistry. 2005, NOV 15; 44(45): 15053-15063.
  1. 13.   A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
  2. Burger, A. M.; Gao, Y. G.; Amemiya, Y.; Kahn, H. J.; Kitching, R.; Yang, Y. L.; Sun, P.; Narod, S. A.; Hanna, W. M.; Seth, A. K.
  3. Cancer Research. 2005, NOV 15; 65(22): 10401-10412.
  1. 14.   Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
  2. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V. E.; Kelley, J. A.; Agbaria, R.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 121-133.
  1. 15.   Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L
  2. Lee, J. K.; Seki, N.; Sayers, T. J.; Subleski, J.; Gruys, E. M.; Murphy, W. J.; Wiltrout, R. H.
  3. Cellular Immunology. 2005, JUN; 235(2): 145-152.
  1. 16.   Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer
  2. Palmieri, D.; Halverson, D. O.; Ouatas, T.; Horak, C. E.; Salerno, M.; Johnson, J.; Figg, W. D.; Hollingshead, M.; Hursting, S.; Berrigan, D.; Steinberg, S. M.; Merino, M. J.; Steeg, P. S.
  3. Journal of the National Cancer Institute. 2005, MAY 4; 97(9): 632-642.
  1. 17.   Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis
  2. Brooks, A. D.; Sayers, T. J.
  3. Cancer Immunology Immunotherapy. 2005, MAY; 54(5): 499-505.
  1. 18.   Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J.; Anderson, L. M.
  3. Oncogene. 2005, MAR 10; 24(11): 1847-1859.
  1. 19.   Cytotoxicity of RH1: NAD(P)H : quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction
  2. Tudor, G.; Alley, M.; Nelson, C. M.; Huang, R. L.; Covell, D. G.; Gutierrez, P.; Sausville, E. A.
  3. Anti-Cancer Drugs. 2005 16(4): 381-391.
  1. 20.   Arylthioindoles, potent inhibitors of tubulin polymerization
  2. De Martino, G.; La Regina, G.; Coluccia, A.; Edler, M. C.; Barbera, M. C.; Brancale, A.; Wilcox, E.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2004, DEC 2; 47(25): 6120-6123.
  1. 21.   Components of the cell death machine and drug sensitivity of the National Cancer Institute cell line panel
  2. Svingen, P. A.; Loegering, D.; Rodriquez, J.; Meng, X. W.; Mesner, P. W.; Holbeck, S.; Monks, A.; Krajewski, S.; Scudiero, D. A.; Sausville, E. A.; Reed, J. C.; Lazebnik, Y. A.; Kaufmann, S. H.
  3. Clinical Cancer Research. 2004, OCT 15; 10(20): 6807-6820.
  1. 22.   Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones
  2. Raffa, D.; Edler, M. C.; Daidone, G.; Maggio, B.; Merickech, M.; Plescia, S.; Schillaci, D.; Bai, R. L.; Hamel, E.
  3. European Journal of Medicinal Chemistry. 2004 39(4): 299-304.
  1. 23.   Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence
  2. Kammouni, W.; Ramakrishna, G.; Sithanandam, G.; Smith, G. T.; Fornwald, L. W.; Masuda, A.; Takahashi, T.; Anderson, L. M.
  3. Cell Growth and Differentiation. 2002 13(9): 441-448.
  1. 24.   Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms
  2. Tan, A. R.; Headlee, D.; Messmann, R.; Sausville, E. A.; Arbuck, S. G.; Murgo, A. J.; Melillo, G.; Zhai, S. P.; Figg, W. D.; Swain, S. M.; Senderowicz, A. M.
  3. Journal of Clinical Oncology. 2002 20(19): 4074-4082.
  1. 25.   Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of ras via a histidine protein kinase pathway
  2. Hartsough, M. T.; Morrison, D. K.; Salerno, M.; Palmieri, D.; Ouatas, T.; Mair, M.; Patrick, J.; Steeg, P. S.
  3. Journal of Biological Chemistry. 2002 277(35): 32389-32399.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel